Dow Up 1.31% Nasdaq Up 2.40%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
11.55 0.64(5.25%) Oct 21, 4:00PM EDT
Prev Close:12.19
Open:12.39
Bid:11.50 x 200
Ask:14.19 x 200
1y Target Est:21.00
Beta:4
Next Earnings Date:N/A
Day's Range:11.15 - 12.54
52wk Range:6.52 - 15.80
Volume:2,420,540
Avg Vol (3m):1,571,480
Market Cap:697.60M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INODown 5.25%697.60M
AZN87.15B
PFE179.32B
SNY136.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):42.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback